Clinical Trials Browser

Phase 1 × Prostatic Neoplasms × ZD4054 × Clear all

NCT00314782 2013-03-12

Phase I Study of ZD4054 (Zibotentan) and Docetaxel in Patients With Metastatic HRPC

Phase 1 Completed

Prostatic Neoplasms